C.P. Thakur

4.8k total citations · 1 hit paper
73 papers, 3.6k citations indexed

About

C.P. Thakur is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Parasitology. According to data from OpenAlex, C.P. Thakur has authored 73 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Public Health, Environmental and Occupational Health, 19 papers in Epidemiology and 15 papers in Parasitology. Recurrent topics in C.P. Thakur's work include Research on Leishmaniasis Studies (50 papers), Trypanosoma species research and implications (19 papers) and Parasites and Host Interactions (13 papers). C.P. Thakur is often cited by papers focused on Research on Leishmaniasis Studies (50 papers), Trypanosoma species research and implications (19 papers) and Parasites and Host Interactions (13 papers). C.P. Thakur collaborates with scholars based in India, Switzerland and United Kingdom. C.P. Thakur's co-authors include T. K. Jha, Shyam Sundar, Christina Fischer, Avinash Pandey, A.D.M. Bryceson, Juergen Engel, H. Sindermann, Klaus Junge, Piero Olliaro and Jonathan Berman and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

C.P. Thakur

69 papers receiving 3.4k citations

Hit Papers

Oral Miltefosine for Indian Visceral Leishmaniasis 2002 2026 2010 2018 2002 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C.P. Thakur India 34 3.1k 1.8k 690 498 221 73 3.6k
Max Grögl United States 35 2.7k 0.9× 1.7k 1.0× 568 0.8× 449 0.9× 256 1.2× 76 3.3k
Ana Rabello Brazil 32 2.6k 0.8× 1.4k 0.8× 796 1.2× 202 0.4× 161 0.7× 109 3.3k
Johannes Blum Switzerland 29 1.9k 0.6× 1.6k 0.9× 939 1.4× 240 0.5× 282 1.3× 76 3.2k
Sakib Burza Spain 21 1.8k 0.6× 1.1k 0.6× 354 0.5× 256 0.5× 174 0.8× 54 2.4k
Áluízio Prata Brazil 28 1.6k 0.5× 1.8k 1.1× 1.1k 1.5× 188 0.4× 127 0.6× 140 3.0k
Danielle Légaré Canada 27 1.6k 0.5× 1.3k 0.7× 422 0.6× 244 0.5× 477 2.2× 37 2.1k
Peter J. Weina United States 25 1.7k 0.5× 601 0.3× 312 0.5× 146 0.3× 202 0.9× 63 2.3k
Marcos José Marques Brazil 25 1.2k 0.4× 759 0.4× 431 0.6× 201 0.4× 224 1.0× 104 1.9k
María‐Jesús Pinazo Spain 32 2.0k 0.6× 2.6k 1.5× 663 1.0× 555 1.1× 366 1.7× 115 3.2k
Maria Terezinha Bahia Brazil 32 1.8k 0.6× 2.2k 1.2× 488 0.7× 671 1.3× 310 1.4× 92 2.6k

Countries citing papers authored by C.P. Thakur

Since Specialization
Citations

This map shows the geographic impact of C.P. Thakur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.P. Thakur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.P. Thakur more than expected).

Fields of papers citing papers by C.P. Thakur

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.P. Thakur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.P. Thakur. The network helps show where C.P. Thakur may publish in the future.

Co-authorship network of co-authors of C.P. Thakur

This figure shows the co-authorship network connecting the top 25 collaborators of C.P. Thakur. A scholar is included among the top collaborators of C.P. Thakur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.P. Thakur. C.P. Thakur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thakur, C.P., et al.. (2025). Deep learning for object recognition and defect analysis in additive manufacturing. Discover Materials. 5(1).
2.
Thakur, C.P.. (2016). Is elimination of kala-azar feasible by 2017?. The Indian Journal of Medical Research. 144(6). 799–802. 12 indexed citations
3.
Thakur, C.P. & Shyam Narayan. (2004). A comparative evaluation of amphotericin B and sodium antimony gluconate, as first-line drugs in the treatment of Indian visceral leishmaniasis. Annals of Tropical Medicine and Parasitology. 98(2). 129–138. 45 indexed citations
4.
Sundar, Shyam, et al.. (2003). Single‐Dose Liposomal Amphotericin B in the Treatment of Visceral Leishmaniasis in India: A Multicenter Study. Clinical Infectious Diseases. 37(6). 800–804. 97 indexed citations
5.
Sundar, Shyam, T. K. Jha, C.P. Thakur, et al.. (2002). Oral Miltefosine for Indian Visceral Leishmaniasis. New England Journal of Medicine. 347(22). 1739–1746. 568 indexed citations breakdown →
6.
Sundar, Shyam, et al.. (2002). Low-dose liposomal amphotericin B in refractory Indian visceral leishmaniasis: a multicenter study.. American Journal of Tropical Medicine and Hygiene. 66(2). 143–146. 74 indexed citations
7.
Thakur, C.P., et al.. (2000). Miltefosine in a case of visceral leishmaniasis with HIV co-infection; and rising incidence of this disease in India. Transactions of the Royal Society of Tropical Medicine and Hygiene. 94(6). 696–697. 31 indexed citations
8.
Thakur, C.P., Thomas P. Kanyok, Avinash Pandey, et al.. (2000). A prospective randomized, comparative, open-label trial of the safety and efficacy of paromomycin (aminosidine) plus sodium stibogluconate versus sodium stibogluconate alone for the treatment of visceral leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene. 94(4). 429–431. 77 indexed citations
9.
Pathare, Anil, et al.. (1999). Dose-ranging studies on liposomal amphotericin B (L-AMP-LRC-1) in the treatment of visceral leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene. 93(3). 314–318. 33 indexed citations
10.
Jha, T. K., C.P. Thakur, Peter Bachmann, et al.. (1999). Miltefosine, an Oral Agent, for the Treatment of Indian Visceral Leishmaniasis. New England Journal of Medicine. 341(24). 1795–1800. 360 indexed citations
11.
Berman, J D, Roberto Badaró, C.P. Thakur, et al.. (1998). Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries.. Europe PMC (PubMed Central). 76(1). 25–32. 128 indexed citations
12.
Thakur, C.P.. (1997). Amphotericin B is superior to sodium antimony gluconate in the treatment of Indian post kala azar dermal leishmaniasis. Annals of Tropical Medicine and Parasitology. 91(6). 611–616. 49 indexed citations
13.
Thakur, C.P., et al.. (1995). Aminosidine plus sodium stibogluconate for the treatment of Indian kala-azar: a randomized dose-finding clinical trial. Transactions of the Royal Society of Tropical Medicine and Hygiene. 89(2). 219–223. 51 indexed citations
14.
Thakur, C.P., et al.. (1994). A kala-azar control programme for remote tribal communities.. PubMed. 15(3). 245–7. 4 indexed citations
15.
Thakur, C.P.. (1994). Comparison of glucose versus fat emulsion in the preparation of amphotericin B for use in kala-azar. Transactions of the Royal Society of Tropical Medicine and Hygiene. 88(6). 698–699. 17 indexed citations
16.
Thakur, C.P. & Prabhat Kumar Sinha. (1989). Inefficacy of ethambutol, ethambutol plus isoniazid, INH plus rifampicin, co-trimoxazole and metronidazole in the treatment of kala-azar.. PubMed. 92(6). 383–5. 5 indexed citations
17.
Thakur, C.P.. (1987). Chemotherapy of leishmaniasis in India. The Indian Journal of Pediatrics. 54(1). 7–10.
18.
Thakur, C.P., et al.. (1984). Full moon and crime.. BMJ. 289(6460). 1789–1791. 44 indexed citations
19.
Thakur, C.P., Manish Kumar, Deborshi Sharma, et al.. (1984). Comparison of regimens of treatment with sodium stibogluconate in kala-azar.. BMJ. 288(6421). 895–897. 48 indexed citations
20.
Thakur, C.P., et al.. (1980). Full moon and poisoning.. BMJ. 281(6256). 1684.1–1684. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026